Investor Type

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top right of this site.
Institutional Investor Advisor Individual Investor


Emerging Markets Set for Upside Surprises

March 27, 2017

Emerging market (EM) equities continue to be the unloved asset class of choice, an aversion that has been amplified by rising U.S. interest rates, a stronger U.S. dollar and the election of Donald Trump.

Over the last five years through December 2016, the MSCI Emerging Markets Index underperformed the MSCI EAFE Index by 80% on an annualized basis. It has also trailed the S&P 500 Index by a significant margin since mid 2013 (Exhibit 1). The performance gap widened after Trump took office and began to dismantle trade agreements, but has begun to show signs of closing (Exhibit 2). EM stocks currently trade at a 30% discount to developed market (DM) stocks on a forward P/E basis and are under-owned by investors. The greater the level of pessimism, the lower the bar is set for EM companies to exceed depressed expectations.

Exhibit 1: Emerging Market Stock Performance Has Diverged from the U.S... 

Data from Jan. 2, 2009 - Nov. 4, 2016. Source: Bloomberg. 


Exhibit 2: ...But the Gap is Narrowing

Data from Nov. 9, 2016 - March 22, 2017. Source: Bloomberg.


Recent struggles have coincided with slowing economic growth and sharply falling currencies across major emerging markets including Brazil, Russia, Turkey and South Africa. EM currencies have fallen below 2009 crisis levels and are significantly undervalued. This has historically led to U.S. dollar (USD)-based debt repayment difficulties and defaults. But most countries have learned this lesson after the 1998 Asian financial crisis and built up a solid buffer of foreign exchange reserves. This allows for the improvement in competitiveness and the terms of trade to bolster exports without risk of a debt crisis. EM economies are highly correlated to commodities, and this area appears to have troughed as well.

Recent EM currency weakness has resulted from acceleration in the USD that is now likely behind us. The yield spread between the 10-year U.S. Treasury and 10-year German Bund is at a 30-year high, suggesting interest rate differentials are at or near their peak and further USD appreciation is less probable. Additionally, the declining GDP growth premium of EM economies versus DM economies over the past few years is likely nearing a nadir. As EM growth improves relative to DM and currencies stabilize, improved corporate profit growth and sentiment should follow on, ultimately leading to capital markets outperformance. In our view, EM equities have endured their crisis and are on the road to recovery.

Most major DM economies - U.S., Eurozone, Japan - are improving, which should benefit EM companies that are highly levered to global growth. China is no longer expanding at a 9% rate, but growth is unlikely to drop below 5% as its central bank is stimulating again. As shown in Exhibit 3, consumption has stabilized in China and emerging Asia and is now trending in the same positive direction as Western economies.


Exhibit 3: Emerging Asia consumption has been stronger than anywhere else

Real household consumption YoY change, 3-year CMA. Other EM Asia excludes China. Source: Gavekal Data/Macrobond.


Financials are a good illustration of these cyclical ties to global growth. In our International Value strategies, we own several European banks with significant exposure to emerging markets: Standard Chartered generates most of its business in Asia, Banco Santander is a major lender in Latin America while Itau Unibanco is a Brazilian bank with direct exposure to the recovery of Latin America's largest economy.

Our optimism is tempered by acknowledgement of the risks that linger in emerging markets. The passage of U.S. border tax adjustments, a more hawkish U.S. Federal Reserve, continued negative trade rhetoric, geopolitical risk and the potential for a sharp rollover in China are all concerns we are monitoring. If these risks were to materialize, we believe already depressed EM valuations are less likely to be punished than those in markets with higher valuations and higher expectations. 

Safa Muhtaseb, CFA

Portfolio Manager
30 Years experience
10 Years at ClearBridge

Related Blog Posts

  • All opinions and data included in this commentary are as of March 24, 2017 and are subject to change. The opinions and views expressed herein are of Safa Muhtaseb and may differ from other managers, or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments nor its information providers are responsible for any damages or losses arising from any use of this information.


  • Past performance is no guarantee of future results.

  • Performance source: Internal. Benchmark source: Morgan Stanley Capital International. Neither ClearBridge Investments, LLC nor its information providers are responsible for any damages or losses arising from any use of this information. Performance is preliminary and subject to change.

    Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI’s express written consent. Further distribution is prohibited.